Coca-Cola has struggled to integrate its $5.6 billion purchase of BodyArmor with Powerade, which led to more “disruption in the short-term” than expected, according to CEO James Quincey.
Body Armor’s sales declined in the latest quarter.
The Atlanta-based Coca-Cola is optimistic that BodyArmor will eventually complement Powerade, its other big offering in the sports-drink category, as it aims to better compete against industry heavyweight, Pepsi-owned Gatorade.
BodyArmor’s purchase is the largest acquisition in Coca-Cola’s history.
In 2018, Coca-Cola first paid an undisclosed sum for a 15% share in BodyArmor, which had revenues of around $250 million.
That amount increased to more than $1 billion in 2021 when it acquired the remaining shares of brand to increase the variety of beverages it offers.
Through the use of coconut water, low sodium and high potassium levels, the lack of artificial colors, and the addition of sugar in place of high fructose corn syrup, the fast-growing, healthier sports drink gained popularity among consumers.
The purchase of BodyArmor by Coca-Cola led to a big bet that the beverage would play a key role in building out its liquid offerings and repositioning the business into a “total beverage company.”
Coca-Cola’s U.S. sports-drink market share had slipped in recent months. Still, the Coke chief remains optimistic this year will be a turning point for BodyArmor.


Japan Posts First Current Account Deficit in 17 Months as Dividend Payments Surge
Venezuela Earthquake Health Risks Rise as Disease Monitoring Intensifies
Hanwha Offers Up to $1.2 Billion for Austal US Business
Trump Draws Cheers at Ryder Cup as U.S. Trails Europe After Opening Day
Trump Administration Bars U.S. Travelers From Congo Flights Amid Ebola Outbreak
Netflix, Disney, YouTube Eye FIFA World Cup TV Rights in Multi-Billion Dollar Battle
Nvidia Secures $500 Billion AI Infrastructure Push With Wall Street Giants
US-Backed Pediatric HIV Treatment Drops After Foreign Aid Changes, Study Finds
JD Vance to Lead U.S. Presidential Delegation at Milano Cortina Winter Olympics Opening Ceremony
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook
Japan Executives Warn Weak Yen and Currency Volatility Threaten Economy
Asian Stocks Mixed as RBA Holds Rates, Oil Risks Rise
NBA Returns to China with Alibaba Partnership and Historic Macau Games
Cloudflare Stock Jumps 15% as Earnings Beat Estimates, 2026 Outlook Raised
Asian Stocks Rise as Weak US Jobs Data Eases Fed Rate Hike Fears 



